Harmony Biosciences to be Added to the S&P SmallCap 600® Index
PLYMOUTH MEETING, Pa., Oct. 21, 2021 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that…
Comments Off on Harmony Biosciences to be Added to the S&P SmallCap 600® Index